← Back to Search

Behavioural Intervention

Enhanced Assistance During Radiotherapy for Cancer (EARN Trial)

N/A

Recruiting

Led By Joanna Yang, M.D.

Research Sponsored by Washington University School of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

At least 18 years of age

Planned to receive or currently receiving a protracted course of curative-intent radiotherapy with specific fraction requirements

Must not have

Undergoing treatment for anaplastic thyroid cancer

Planned or scheduled to undergo radiotherapy simulation more than 28 days from the date of consent

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through completion of radiotherapy (estimated to be 4 months)

Awards & highlights

No Placebo-Only Group

Summary

This trial is studying a new program to help patients with unmet needs who are receiving more than 10 radiation therapy sessions. They want to see if this program can help patients finish their treatment on time

Who is the study for?

This trial is for patients with various cancers, including uterine, salivary gland, head and neck, vaginal, esophageal, stomach, bladder, cervical cancer and more. Participants must be undergoing radiotherapy in over 10 sessions.

What is being tested?

The study tests if enhanced assistance during radiotherapy helps patients complete their treatment without delays compared to past data on standard support.

What are the potential side effects?

Since the trial compares different levels of assistance rather than medications or treatments directly affecting health conditions there are no direct side effects from interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am undergoing or scheduled for a specific long-term radiation therapy aimed at curing my condition.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am currently being treated for anaplastic thyroid cancer.

Select...

My radiotherapy simulation is scheduled for more than 28 days after I give consent.

Select...

I am in the hospital and will not have more than 10 radiotherapy sessions as an outpatient.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through completion of radiotherapy (estimated to be 4 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through completion of radiotherapy (estimated to be 4 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and through completion of radiotherapy (estimated to be 4 months) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Delay-free completion of radiotherapy

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Standard Assistance + Enhanced AssistanceExperimental Treatment2 Interventions

In the time period that patients are receiving radiotherapy, study participants will receive standard plus enhanced financial assistance for unmet essential needs.

0 / 5Eligibility criteria met